IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.325
AS - Asia 19.723
EU - Europa 17.477
SA - Sud America 4.489
AF - Africa 531
Continente sconosciuto - Info sul continente non disponibili 509
OC - Oceania 50
Totale 79.104
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.508
SG - Singapore 7.146
IT - Italia 5.550
RU - Federazione Russa 4.954
CN - Cina 4.875
BR - Brasile 3.491
VN - Vietnam 2.576
GB - Regno Unito 1.828
HK - Hong Kong 1.430
BD - Bangladesh 1.393
CA - Canada 1.151
DE - Germania 1.124
FR - Francia 664
SE - Svezia 572
FI - Finlandia 533
IN - India 475
UA - Ucraina 473
IE - Irlanda 461
AR - Argentina 352
MX - Messico 336
NL - Olanda 297
TR - Turchia 289
PL - Polonia 253
ID - Indonesia 230
ES - Italia 204
ZA - Sudafrica 194
EC - Ecuador 184
IQ - Iraq 182
JP - Giappone 177
IL - Israele 172
PK - Pakistan 158
CO - Colombia 124
AT - Austria 107
VE - Venezuela 96
MA - Marocco 85
AE - Emirati Arabi Uniti 82
UZ - Uzbekistan 76
CR - Costa Rica 73
DK - Danimarca 72
LT - Lituania 67
PY - Paraguay 63
CL - Cile 60
EG - Egitto 57
MY - Malesia 56
SA - Arabia Saudita 56
PE - Perù 46
TN - Tunisia 46
KE - Kenya 44
CH - Svizzera 43
JM - Giamaica 40
PH - Filippine 40
BE - Belgio 38
GT - Guatemala 36
HN - Honduras 34
AU - Australia 32
UY - Uruguay 32
BO - Bolivia 31
JO - Giordania 31
AZ - Azerbaigian 30
DZ - Algeria 29
RO - Romania 26
TT - Trinidad e Tobago 24
KZ - Kazakistan 23
CZ - Repubblica Ceca 22
NP - Nepal 22
TH - Thailandia 21
DO - Repubblica Dominicana 20
SV - El Salvador 20
OM - Oman 19
PT - Portogallo 19
EU - Europa 17
IR - Iran 17
NI - Nicaragua 17
AL - Albania 16
SK - Slovacchia (Repubblica Slovacca) 16
TW - Taiwan 16
LB - Libano 15
PA - Panama 15
BB - Barbados 13
ET - Etiopia 13
GR - Grecia 13
KR - Corea 13
AM - Armenia 12
BG - Bulgaria 12
KG - Kirghizistan 12
HU - Ungheria 11
NZ - Nuova Zelanda 11
PR - Porto Rico 11
PS - Palestinian Territory 11
GE - Georgia 10
RS - Serbia 10
CI - Costa d'Avorio 9
HR - Croazia 9
LV - Lettonia 9
MD - Moldavia 9
SN - Senegal 9
BH - Bahrain 8
BY - Bielorussia 8
EE - Estonia 8
GY - Guiana 8
Totale 78.432
Salva come PNG Salva come JPEG
Città #
Dallas 6.253
Singapore 3.716
San Jose 2.915
Ashburn 2.698
Beijing 1.783
Council Bluffs 1.655
Chicago 1.491
Los Angeles 1.483
Hong Kong 1.337
Moscow 916
Milan 882
Ho Chi Minh City 838
New York 719
Salt Lake City 616
Rome 606
Santa Clara 580
Buffalo 563
Chandler 562
Southend 543
Hanoi 505
The Dalles 476
Fairfield 462
San Mateo 451
Dublin 445
Houston 429
Phoenix 413
São Paulo 373
Wilmington 363
Woodbridge 363
Lauterbourg 360
Hefei 353
Tampa 352
Helsinki 333
Seattle 328
Cambridge 322
Elk Grove Village 277
Boardman 276
North Bergen 254
Portsmouth 243
Falls Church 237
Pisa 237
Munich 232
Montreal 229
Florence 226
Orem 220
Warsaw 217
Stevenage 215
Ann Arbor 212
Ottawa 212
Beauharnois 193
Jacksonville 192
Brooklyn 189
Naples 170
Mexico City 168
Toronto 166
London 163
Frankfurt am Main 161
Atlanta 157
Dearborn 156
Lawrence 155
Tokyo 151
Istanbul 150
Denver 148
Tel Aviv 146
Sterling 133
Lancaster 130
Miami 129
Stockholm 129
Chennai 126
Poplar 126
Nuremberg 125
Amsterdam 122
Johannesburg 122
Rio de Janeiro 119
Dong Ket 117
Bologna 115
Lappeenranta 107
Da Nang 106
Figino 105
Turin 104
Columbus 103
Boston 102
Haiphong 98
Washington 88
Belo Horizonte 86
Palermo 86
Dulles 79
San Diego 79
Manchester 74
Genoa 70
San Francisco 70
Charlotte 69
Biên Hòa 68
Brasília 67
Detroit 67
Turku 67
Quito 66
Tashkent 66
Ankara 64
Kansas City 61
Totale 45.681
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.862
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.729
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.604
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 912
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 751
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 631
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 508
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 482
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 476
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 466
Echocardiographic and Cardiac Magnetic Resonance Imaging-Derived Strains in Relation to Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy 464
A simple echocardiographic score to rule out cardiac amyloidosis 431
A simple echocardiographic score to rule out cardiac amyloidosis 411
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 386
Building medical knowledge from real world registries: The case of heart failure 379
Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico 370
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 370
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 364
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 359
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 348
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 343
Treating chemoreflex in heart failure: modulation or demolition? 336
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 335
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 332
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 332
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 332
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 323
Eligibility for vericiguat in a real‐world, contemporary heart failure population 320
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 320
[Ten perspectives for research and innovation in cardiac amyloidosis] 316
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 316
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 314
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 314
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 313
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 313
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 312
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 312
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 311
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 308
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 308
RNA-targeting and gene editing therapies for transthyretin amyloidosis 307
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 306
Screening the health status of people working in a university 305
How to take arms against central apneas in heart failure 300
Sex-related differences in chronic heart failure 299
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 298
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 293
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 291
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 288
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 287
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 287
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 286
Unmet needs in end-of-life care for heart failure patients 284
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 283
Cardiac light-chain deposition disease relapsing in the transplanted heart 282
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 280
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 279
Atrial amyloidosis: mechanisms and clinical manifestations 278
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 275
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 274
Biomarkers for the diagnosis and management of heart failure 271
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 270
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 269
Biomarkers for the diagnosis and management of heart failure: New frontiers 269
Disease features and management of cardiomyopathies in women 268
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 268
Valve disease in cardiac amyloidosis: an echocardiographic score 267
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 265
Assessing cardiac mechanics through left ventricular haemodynamic forces 264
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 264
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 261
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 260
Cardiac magnetic resonance in patients with muscular dystrophies 260
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 259
null 258
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 258
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 258
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 258
null 258
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 257
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 256
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 255
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 255
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 254
Role of Imaging in Cardiomyopathies 253
null 253
Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis 252
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 249
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 247
Perspectives in noninvasive imaging for chronic coronary syndromes 247
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 247
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 246
Valvular heart disease in patients with cardiac amyloidosis 245
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 245
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 241
Current and emerging treatment options for transthyretin amyloid cardiomyopathy 240
Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction 240
Cardiac troponins as biomarkers for cardiac disease 240
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis 240
Cardiac Amyloidosis: How Its Epidemiology is Changing 239
Totale 35.701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 395.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 395.302
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.001 0 0 0 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.762 107 49 336 122 75 154 106 71 88 96 95 463
2024/202519.231 220 243 878 362 665 803 1.951 3.264 1.352 2.501 4.166 2.826
2025/202642.265 2.174 6.164 4.835 5.507 3.995 2.647 4.115 1.973 2.666 2.793 2.750 2.646
2026/20277.143 1.268 1.410 2.611 1.854 0 0 0 0 0 0 0 0
Totale 79.104